TNFSF10 and diabetic kidney disease: Similarly, serum-soluble TRAIL levels were found to be significantly suppressed in a cohort of 22 insulin-treated T2DM patients with diabetic nephropathy expressed as macroalbuminuria and foot ulcers [27].